Primary |
Product Used For Unknown Indication |
33.3% |
Drug Use For Unknown Indication |
28.5% |
Pain |
6.3% |
Hypertension |
4.2% |
Back Pain |
3.5% |
Neuralgia |
3.5% |
Analgesic Therapy |
2.8% |
Prostate Cancer Metastatic |
2.8% |
Metastatic Renal Cell Carcinoma |
2.1% |
Phantom Pain |
2.1% |
Arthralgia |
1.4% |
Breakthrough Pain |
1.4% |
Constipation |
1.4% |
Deep Vein Thrombosis |
1.4% |
Lung Squamous Cell Carcinoma Metastatic |
1.4% |
Prophylaxis |
1.4% |
Abdominal Pain |
0.7% |
Abdominal Pain Upper |
0.7% |
Agitation |
0.7% |
Anxiety |
0.7% |
|
Vomiting |
23.5% |
Somnolence |
8.8% |
Confusional State |
5.9% |
Inappropriate Schedule Of Drug Administration |
5.9% |
Malignant Neoplasm Progression |
5.9% |
Panic Attack |
5.9% |
Respiratory Arrest |
5.9% |
Adverse Drug Reaction |
2.9% |
Cholelithiasis |
2.9% |
Death |
2.9% |
Delirium |
2.9% |
Drug Diversion |
2.9% |
Drug Prescribing Error |
2.9% |
Dysarthria |
2.9% |
Incorrect Route Of Drug Administration |
2.9% |
Lethargy |
2.9% |
Neoplasm Malignant |
2.9% |
Osteoporotic Fracture |
2.9% |
Pain |
2.9% |
Pancreatitis Acute |
2.9% |
|
Secondary |
Product Used For Unknown Indication |
38.2% |
Drug Use For Unknown Indication |
18.7% |
Pain |
12.5% |
Trigeminal Neuralgia |
4.2% |
Depression |
3.9% |
Cancer Pain |
3.6% |
Analgesic Therapy |
3.2% |
Back Pain |
1.9% |
Prophylaxis |
1.8% |
Delirium |
1.4% |
Constipation |
1.3% |
Hypertension |
1.2% |
Insomnia |
1.2% |
Headache |
1.1% |
Intervertebral Disc Protrusion |
1.1% |
Nausea |
1.1% |
Pneumonia Aspiration |
1.1% |
Breakthrough Pain |
1.0% |
Foetal Exposure During Pregnancy |
0.8% |
Gastric Cancer |
0.8% |
|
Toxic Epidermal Necrolysis |
11.1% |
Somnolence |
10.2% |
Vomiting |
9.3% |
Multiple Drug Overdose |
8.3% |
Transaminases Increased |
7.4% |
Inappropriate Schedule Of Drug Administration |
5.6% |
Respiratory Distress |
5.6% |
Urinary Retention |
4.6% |
Drug Toxicity |
3.7% |
Hypoaesthesia Facial |
3.7% |
Malnutrition |
3.7% |
Pain |
3.7% |
Wrong Technique In Drug Usage Process |
3.7% |
Lethargy |
2.8% |
Myoclonus |
2.8% |
Osteoporotic Fracture |
2.8% |
Pain In Extremity |
2.8% |
Pancreatitis Acute |
2.8% |
Sepsis |
2.8% |
Skin Exfoliation |
2.8% |
|
Concomitant |
Drug Use For Unknown Indication |
22.5% |
Product Used For Unknown Indication |
15.5% |
Pain |
12.9% |
Prophylaxis |
6.9% |
Diffuse Large B-cell Lymphoma |
6.4% |
Hypertension |
3.7% |
Prostate Cancer |
3.4% |
Constipation |
3.0% |
Plasma Cell Myeloma |
2.9% |
Non-small Cell Lung Cancer |
2.8% |
Analgesic Therapy |
2.8% |
Multiple Myeloma |
2.7% |
Cancer Pain |
2.5% |
Back Pain |
2.5% |
Depression |
1.8% |
Nausea |
1.8% |
Bone Pain |
1.6% |
Crohn's Disease |
1.6% |
Gastric Cancer |
1.3% |
Insomnia |
1.2% |
|
Vomiting |
12.6% |
Thrombocytopenia |
8.9% |
Pyrexia |
7.6% |
Weight Decreased |
7.3% |
Urinary Tract Infection |
6.6% |
Renal Failure Acute |
6.3% |
Pain |
6.0% |
Sepsis |
5.0% |
Pulmonary Embolism |
4.6% |
Death |
4.3% |
Tremor |
4.3% |
General Physical Health Deterioration |
3.6% |
Pneumonia |
3.3% |
Tooth Extraction |
3.3% |
Tachycardia |
3.0% |
Treatment Failure |
3.0% |
Ascites |
2.6% |
Lung Disorder |
2.6% |
Thrombosis |
2.6% |
Gastric Cancer |
2.3% |
|
Interacting |
Pain |
25.3% |
Headache |
14.5% |
Depression |
10.8% |
Product Used For Unknown Indication |
8.4% |
Pain Prophylaxis |
6.0% |
Epilepsy |
3.6% |
Hepatic Neoplasm Malignant |
3.6% |
Neuralgia |
3.6% |
Prophylaxis |
3.6% |
Rhinitis Allergic |
3.6% |
Arthralgia |
2.4% |
Back Pain |
2.4% |
Drug Use For Unknown Indication |
2.4% |
Sarcoidosis |
2.4% |
Analgesia |
1.2% |
Anxiety |
1.2% |
Breakthrough Pain |
1.2% |
Cancer Pain |
1.2% |
Gastrooesophageal Reflux Disease |
1.2% |
Gout |
1.2% |
|
Malnutrition |
16.7% |
Somnolence |
16.7% |
Confusional State |
8.3% |
Disturbance In Attention |
8.3% |
Hyperhidrosis |
8.3% |
Miosis |
8.3% |
Shock |
8.3% |
Surgery |
8.3% |
Urinary Retention |
8.3% |
Wrong Technique In Drug Usage Process |
8.3% |
|